These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


787 related items for PubMed ID: 20367670

  • 1. Photodynamic therapy for acne vulgaris: a randomized, controlled, split-face clinical trial of topical aminolevulinic acid and pulsed dye laser therapy.
    Orringer JS, Sachs DL, Bailey E, Kang S, Hamilton T, Voorhees JJ.
    J Cosmet Dermatol; 2010 Mar; 9(1):28-34. PubMed ID: 20367670
    [Abstract] [Full Text] [Related]

  • 2. Long-pulsed dye laser-mediated photodynamic therapy combined with topical therapy for mild to severe comedonal, inflammatory, or cystic acne.
    Alexiades-Armenakas M.
    J Drugs Dermatol; 2006 Jan; 5(1):45-55. PubMed ID: 16468292
    [Abstract] [Full Text] [Related]

  • 3. Radiant near infrared light emitting Diode exposure as skin preparation to enhance photodynamic therapy inflammatory type acne treatment outcome.
    Barolet D, Boucher A.
    Lasers Surg Med; 2010 Feb; 42(2):171-8. PubMed ID: 20166163
    [Abstract] [Full Text] [Related]

  • 4. Treatment of inflammatory facial acne vulgaris with intense pulsed light and short contact of topical 5-aminolevulinic acid: a pilot study.
    Rojanamatin J, Choawawanich P.
    Dermatol Surg; 2006 Aug; 32(8):991-6; discussion 996-7. PubMed ID: 16918560
    [Abstract] [Full Text] [Related]

  • 5. Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in combination with topical keratolytic agents.
    de Leeuw J, van der Beek N, Bjerring P, Neumann HA.
    J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):460-9. PubMed ID: 19796088
    [Abstract] [Full Text] [Related]

  • 6. A randomized, controlled, split-face clinical trial of 1320-nm Nd:YAG laser therapy in the treatment of acne vulgaris.
    Orringer JS, Kang S, Maier L, Johnson TM, Sachs DL, Karimipour DJ, Helfrich YR, Hamilton T, Voorhees JJ.
    J Am Acad Dermatol; 2007 Mar; 56(3):432-8. PubMed ID: 17239987
    [Abstract] [Full Text] [Related]

  • 7. The use of a novel intense pulsed light and heat source and ALA-PDT in the treatment of moderate to severe inflammatory acne vulgaris.
    Gold MH, Bradshaw VL, Boring MM, Bridges TM, Biron JA, Carter LN.
    J Drugs Dermatol; 2004 Mar; 3(6 Suppl):S15-9. PubMed ID: 15624737
    [Abstract] [Full Text] [Related]

  • 8. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action.
    Pollock B, Turner D, Stringer MR, Bojar RA, Goulden V, Stables GI, Cunliffe WJ.
    Br J Dermatol; 2004 Sep; 151(3):616-22. PubMed ID: 15377348
    [Abstract] [Full Text] [Related]

  • 9. A comparison of intense pulsed light, combination radiofrequency and intense pulsed light, and blue light in photodynamic therapy for acne vulgaris.
    Taub AF.
    J Drugs Dermatol; 2007 Oct; 6(10):1010-6. PubMed ID: 17966178
    [Abstract] [Full Text] [Related]

  • 10. A comparative split-face study of photodynamic therapy with indocyanine green and indole-3-acetic acid for the treatment of acne vulgaris.
    Jang MS, Doh KS, Kang JS, Jeon YS, Suh KS, Kim ST.
    Br J Dermatol; 2011 Nov; 165(5):1095-100. PubMed ID: 21692772
    [Abstract] [Full Text] [Related]

  • 11. Topical aminolevulinic acid-photodynamic therapy for the treatment of acne vulgaris.
    Hong SB, Lee MH.
    Photodermatol Photoimmunol Photomed; 2005 Dec; 21(6):322-5. PubMed ID: 16313244
    [Abstract] [Full Text] [Related]

  • 12. Topical ALA PDT for the treatment of severe acne vulgaris.
    Wang XL, Wang HW, Zhang LL, Guo MX, Huang Z.
    Photodiagnosis Photodyn Ther; 2010 Mar; 7(1):33-8. PubMed ID: 20230991
    [Abstract] [Full Text] [Related]

  • 13. A review of photodynamic therapy (PDT) for the treatment of acne vulgaris.
    Riddle CC, Terrell SN, Menser MB, Aires DJ, Schweiger ES.
    J Drugs Dermatol; 2009 Nov; 8(11):1010-9. PubMed ID: 19894368
    [Abstract] [Full Text] [Related]

  • 14. Treatment of moderate to severe inflammatory acne vulgaris: photodynamic therapy with 5-aminolevulinic acid and a novel advanced fluorescence technology pulsed light source.
    Gold MH, Biron JA, Boring M, Bridges TM, Bradshaw VL.
    J Drugs Dermatol; 2007 Mar; 6(3):319-22. PubMed ID: 17373194
    [Abstract] [Full Text] [Related]

  • 15. Photodynamic therapy with intralesional 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone in the treatment of acne vulgaris: a comparative study.
    Shaaban D, Abdel-Samad Z, El-Khalawany M.
    Dermatol Ther; 2012 Mar; 25(1):86-91. PubMed ID: 22591502
    [Abstract] [Full Text] [Related]

  • 16. Low-dose topical 5-aminolevulinic acid photodynamic therapy in the treatment of different severity of acne vulgaris.
    Ma L, Xiang LH, Yu B, Yin R, Chen L, Wu Y, Tan ZJ, Liu YB, Tian HQ, Li HZ, Lin T, Wang XL, Li YH, Wang WZ, Yang HL, Lai W.
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):583-90. PubMed ID: 24284115
    [Abstract] [Full Text] [Related]

  • 17. Photodynamic therapy for the treatment of acne: a pilot study.
    Taub AF.
    J Drugs Dermatol; 2004 Dec; 3(6 Suppl):S10-4. PubMed ID: 15624736
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of ALA-PDT vs blue light in the treatment of acne.
    Akaraphanth R, Kanjanawanitchkul W, Gritiyarangsan P.
    Photodermatol Photoimmunol Photomed; 2007 Oct; 23(5):186-90. PubMed ID: 17803597
    [Abstract] [Full Text] [Related]

  • 19. Liposomal methylene blue hydrogel for selective photodynamic therapy of acne vulgaris.
    Fadel M, Salah M, Samy N, Mona S.
    J Drugs Dermatol; 2009 Nov; 8(11):983-90. PubMed ID: 19894365
    [Abstract] [Full Text] [Related]

  • 20. Intense pulsed light vs. pulsed-dye laser in the treatment of facial acne: a randomized split-face trial.
    Choi YS, Suh HS, Yoon MY, Min SU, Lee DH, Suh DH.
    J Eur Acad Dermatol Venereol; 2010 Jul; 24(7):773-80. PubMed ID: 20002654
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 40.